JOSE MANUEL
VALDIVIELSO REVILLA
CON
Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (6)
2024
-
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189
-
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease
Clinical Kidney Journal, Vol. 17, Núm. 3
2023
-
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25
2015
-
Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells
BioMed Research International, Vol. 2015
-
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
Atherosclerosis, Vol. 239, Núm. 2, pp. 358-363
2013
-
Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease
Journal of Nephrology, Vol. 26, Núm. 6, pp. 1105-1113